FogPharma
Creating extraordinary medicines.
Cambridge, United States · Founded 2016 · $801.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- fogpharma.com
- Total Funding
- $801.0M
- Last Round
- $305.0M Series FJan 2025
- Rounds
- 5
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
FogPharma (rebranded as Parabilis Medicines in October 2024) is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company pioneered a new class of alpha-helical peptides called Helicons™, capable of modulating intracellular proteins historically beyond the reach of conventional medicines. Its lead program, FOG-001 (zolucatetide), is the first and only direct inhibitor of the beta-catenin transcriptional co-activator complex and is in active clinical development across multiple tumor types including adamantinomatous craniopharyngioma. In January 2026, Parabilis raised an oversubscribed $305 million financing to advance FOG-001 and its broader Helicon platform.
Summary
FogPharma is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $801.0M in total across 5 rounds, most recently a $305.0M Series F round in Jan 2025. Investors include RA Capital Management, venBIO Partners and ARCH Venture Partners.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
2025 (est.)
Sign up to see all 5 events
Funding: Series B through Series F. Amounts, valuations, and investors where available.
Investors
RA Capital Management
2 rounds
venBIO Partners
2 rounds
ARCH Venture Partners
2 rounds
Nextech Invest
1 round
6 Dimensions Capital
1 round
Cormorant Asset Management
1 round
Rock Springs Capital
1 round
General Catalyst
1 round
Marshall Wace
1 round
Invus
1 round
Milky Way Investments Group
1 round
Fidelity Management
1 round
GV
1 round
Blue Pool Capital
1 round
Deerfield Management
1 round
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/fogpharma"><img src="https://indexed.vc/api/badge/company/fogpharma" alt="FogPharma on Indexed.vc" width="260" height="76" /></a>